This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Hyaluronic Acid
Cheap, safe glycosaminoglycan supplement with B-tier evidence for knee osteoarthritis pain (oral 80-200mg/day × 8-12+ weeks) and skin hydration/elasticity at midlife.
Aliases (19)
Overview
What is Hyaluronic Acid?
Cheap, safe glycosaminoglycan supplement with B-tier evidence for knee osteoarthritis pain (oral 80-200mg/day × 8-12+ weeks) and skin hydration/elasticity at midlife. Mechanism is real: low-MW oral HA is depolymerized to oligosaccharides, absorbed, redistributed to joint + skin tissue, and acts via CD44/TLR2-4 immunomodulation plus direct matrix incorporation. For Dylan — a 20yo MMA athlete with healthy joints + good base diet — standalone oral HA is OPTIONAL-ADD with modest expected upside; pairs best as one component of a 4-5-piece joint-resilience stack (collagen + omega-3 + vitamin C + glucosamine ± boswellia) during heavy training blocks or post-injury. Intra-articular HA injection (Synvisc, Euflexxa, Durolane) is a separate, stronger evidence-base modality — Rx-only, reserved for moderate-severe knee OA + selected post-surgical joint cases; irrelevant unless specific traumatic joint injury occurs. Bacterial-fermentation source (vegan, cleaner) > rooster-comb. Dose 60-200mg/day, anytime, with food. Safety: very benign — rare GI upset, theoretical CD44/tumor concern has no clinical signal at supplement doses. No cycling needed.
Research Protocols
Disclaimer: These are commonly discussed research protocols and not medical advice.
Peptide Interactions
classic joint-stack pairing. Collagen provides Gly/Pro/Hyp substrate for matrix synthesis; HA provides viscoelastic + signaling component. Multiple RCTs comb…
synergistic for joint matrix support. Glucosamine is a substrate for HA synthesis (the N-acetylglucosamine half of the HA disaccharide); chondroitin is a sul…
cofactor for prolyl + lysyl hydroxylase in collagen synthesis; supports joint matrix integrity broadly. Already in most stacks.
anti-inflammatory action complements HA's CD44/TLR-mediated immunomodulation at joint. Already in Dylan's V4.
AKBA inhibits 5-LOX → reduces leukotriene-driven inflammation. Complementary to HA pathway. Adds well during heavy training cycles.
NFκB inhibition + anti-inflammatory; complements HA. Already in Dylan's V4.
sulfur donor for chondroitin synthesis + general joint support. Modest standalone evidence; layers without conflict.
for post-injury joint + tendon recovery. HA + BPC-157 + TB-500 is the standard tendon + ligament repair stack in athletic populations. Dylan's planned V5 pep…
HA is essentially inert outside its target receptors. No CYP interactions, no displacement of bound drugs, no anticoagulant or pro-coagulant effects of note.
theoretical chelation of GAG fragments; separate by 2 hours if both are needed.
no documented conflict but the combination is rarely necessary; if undergoing IA injection, oral can continue without modification.
What to Expect
- Week 1Tolerability and dose-response.
- Week 2-4Early effect window.
- Week 4-8Peak benefit assessment.
- Week 8+Cycle decision point.
Side Effects & Safety 4
Side Effects
- 1Effectively none in oral form. GI tolerance is exceptional — HA is essentially a long-chain sugar polymer, well-tolerated by gut microbiome.
- 2Digestive upset: ~3-5% — mild bloating, soft stool, occasional nausea, particularly at higher doses (>200mg) or in fasted state. Resolves on dose reduction or with-food administration.
- 3Mild fatigue: ~2-3% in community reports — mechanism unclear, possibly coincidence or fluctuation in concurrent stack.
- 4Headache: ~1-2% in some trials; usually transient first-week effect.
When to Stop
- Intra-articular injection: transient injection-site pain + effusion (~5-10% of injections); rare pseudoseptic arthritis (sterile inflammatory response); rare anaphylaxis (avian-derived HA in egg-allergic patients).
- Topical: rare contact dermatitis; very rare angioedema.
- Oral allergic reactions: vanishingly rare; rooster-comb-derived HA has occasionally triggered reactions in poultry/egg-allergic patients — bacterial-fermentation HA avoids this.
- Weeks 1-2: GI adjustment — if bloating or soft stool, switch to with-food administration and reduce dose to 80mg.
- Months 2-3: primary efficacy window — if no skin or joint subjective improvement by month 3, discontinue (non-responder).
- No long-term cumulative toxicity has been documented across 25+ years of widespread oral HA use.
References
Oe et al. 2017 — Oral hyaluronan relieves wrinkles: 12-week RCT
PMID 28761365 (verified). 120mg/day × 12 weeks, 60 Japanese women aged 22-59; significant wrinkle-depth reduction at 8 weeks + skin luster/suppleness improvement by 12 weeks.
View StudyOe et al. 2016 — Oral hyaluronan relieves knee pain: narrative review
synthesis of 13 oral HA RCTs in knee OA; consistent modest VAS/WOMAC improvement at 80-200mg/day over 8-12+ weeks.
View StudyTashiro et al. 2012 — Oral polymer hyaluronic acid for knee OA: 12-month RCT
ScientificWorldJournal 2012. 200mg/day × 12 months in mild-moderate knee OA; significant VAS pain + WOMAC improvement vs placebo.
View StudyKalman et al. 2008 — Hyal-Joint (chicken comb HA) for knee OA
Nutrition Journal 2008. 80mg/day × 8 weeks; pain relief and QoL improvement.
View StudyKawada et al. 2014 — Oral hyaluronan for skin moisture: RCT
corneometer + TEWL improvement at 120mg/day × 6 weeks in adults with dry skin.
View StudySato et al. 2014 — Oral HA + skin elasticity RCT
skin elasticity + hydration improvement at 240mg/day × 12 weeks.
View StudyBalogh et al. 2008 — Oral HA absorption, tissue affinity in rats and dogs
J Agric Food Chem 2008. Tracer study establishing oral HA depolymerization → fragment absorption → joint + skin tissue redistribution.
View StudyKimura et al. 2016 — Oral HA pharmacokinetics + tissue distribution human study
confirmed bioavailability + tissue redistribution in humans.
View StudyCochrane review — Viscosupplementation for knee osteoarthritis
meta-analysis of IA HA injection trials; moderate effect size for pain + function.
View StudyOARSI guidelines — Knee osteoarthritis non-surgical management
position statement on IA HA viscosupplementation (qualified recommendation).
View StudyBioiberica Mobilee clinical evidence summary
sponsor-curated summary of Mobilee + Hyal-Joint clinical trials.
View StudyStern + Maibach 2008 — Hyaluronan in skin: aspects of aging
foundational review of HA dermal biology + age-related decline.
View StudySchauss et al. 2012 — BioCell Collagen for joint discomfort: RCT
combined HA + collagen + chondroitin (BioCell) for activity-related joint discomfort; n=80 RCT.
View StudyMaheu et al. 2019 — EULAR / OARSI recommendations on IA HA injection
current European guidance for IA HA in knee OA.
View StudyToole 2004 — Hyaluronan: from extracellular glue to pericellular cue (Nature Reviews Cancer)
landmark review of HA-CD44 biology including tumor relevance; foundational for understanding the theoretical oncology concern.
View StudyLatest research
- rctOral hyaluronan relieves wrinkles: a double-blinded, placebo-controlled 12-week RCT120mg/day oral hyaluronan (both 2k and 300k MW) over 12 weeks significantly reduced wrinkle depth at 8 weeks (300k MW group), improved skin luster + suppleness in all groups by week 12. n=60 Japanese women aged 22-59. PMID 28761365.
- rctOral hyaluronan moisturizes dry skin120mg/day oral HA × 6 weeks increased skin moisture content (corneometer) + reduced trans-epidermal water loss in adults with dry skin. PMID 28761365 — Oe et al. Clin Cosmet Investig Dermatol.
- reviewOral hyaluronan relieves knee pain — narrative review of clinical trial evidenceSynthesis of 13 oral HA RCTs (mostly Japanese) — consistent modest VAS/WOMAC improvement in knee OA at 80-200mg/day over 8-12+ weeks. Effect size small-to-moderate; B-tier evidence.
How was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.